DNA.

Industries

Health

clinics · surgery · telemedicine

Restricted

Clinics, surgical practices and telemedicine. Medical advertising is restricted twice over — by the platforms and by health regulators — and the limits differ by market, so the country list decides what may be produced before anything is produced.

Two rulebooks, and the stricter one is local

Every ad platform restricts health claims. Separately, most countries regulate medical advertising directly: what a clinic may promise, whether results can be shown, whether a doctor may be named in advertising at all, and what has to be disclosed about qualifications. The local rule is usually the tighter of the two, and it is the one with legal consequences rather than account ones.

So the market list is decided first. The same campaign can be routine in one country and a regulatory problem next door, and finding that out after production is an expensive way to learn it.

Before-and-after

The most persuasive asset in aesthetic and surgical marketing is the one most often rejected. Platforms restrict imagery implying a physical transformation, and health regulators in several markets restrict patient result photography outright. Building a campaign on it is building on something that may be withdrawn at any moment.

What survives is the process: how the consultation works, who performs the procedure, what recovery actually looks like, what the clinic does when something goes wrong. This converts more slowly and it converts patients who arrive already trusting the clinic, which is a materially different patient.

How people choose a clinic

Not from an ad. They see the ad, then they search the clinic, read reviews, look for the doctor by name, and compare two or three. That means paid and organic are not alternatives here — paid creates the consideration and organic decides it, and a clinic with strong ads and an absent search presence pays to send patients to a competitor's page.

What we will not do

Health claims that are not true, guaranteed outcomes, and anything that leans on a fear of illness to force a decision. Beyond the ethics, these are precisely what regulators sanction.

Selected work

Work

The first case studies are being cleared for publication.

Tell us what you are trying to move

One message. What you are selling, which countries, what you spend on ads now. You get an answer from someone who has run it, not from a form.

Start a conversation